Standard Chartered Q2 Profit Rises, Updates Income View; Plans $500 Mln Buyback; Stock Up

standardchartered july29 lt

Shares of Standard Chartered Plc were gaining around 3 percent in the morning trading in London after the British bank reported Friday higher second-quarter results, and updated its forecast for fiscal 2022 income growth. The bank also announced a new $500 million share buyback to start imminently.

Bill Winters, Group Chief Executive, said, "We've posted a strong set of results for the first half of the year, with income up 10 percent on a normalised basis, supported by continued positive momentum in the second quarter, in which we grew income 11 percent. We remain disciplined on expenses, with significant savings delivered and maintained a strong capital position, with a CET1 ratio of 13.9 percent.... We remain confident in the delivery of the financial targets we set out in February."

The company said the start to 2022 has been strong, albeit external conditions remain difficult to predict.

For the full year, the bank now expects income ex-DVA growth of around 10 percent at constant currency. The company earlier expected income growth to slightly exceed the 5-7 percent range.

Standard Chartered also said it is on track to deliver 10 percent return on tangible equity by 2024 if not earlier.

For the second quarter, profit before tax went up 12 percent to $1.28 billion from last year's $1.15 billion.

Earnings per share increased 23 percent to 27.2 cents from 22.1 cents a year ago.

Underlying profit before taxation was $1.32 billion, compared to prior year's $1.24 billion. Underlying earnings per share were 28.2 cents, compared to 24.8 cents last year.

Underlying operating profit before impairment and taxation went up 19 percent to $1.30 billion.

Operating income increased 7 percent to $3.93 billion from $3.69 billion in the previous year. Operating income grew 11 percent at constant currency.

Underlying operating income of $3.93 billion grew 6 percent from last year.

In the quarter, net interest income went up 8 percent from last year to $1.85 billion, and the growth was 13 percent at constant currency. Net interest margin improved to 1.35 percent from 1.22 percent last year.

In London, Standard Chartered shares were trading at 580.80 pence, up 2.5 percent. In Hong Kong, the shares settled on Friday at HK$56.05, up 0.27 percent.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT